Pharmaceutical company Bristol-Myers has been in a downtrend since 2016 and after unveiling its merger with Celgene. Is now the right time to buy BMY stock?

source https://finance.yahoo.com/m/9b91df3b-407f-307e-9f6d-4d12736dee02/bmy-stock-plus-celgene-will.html?.tsrc=rss